

| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.0M | +3.3% |
| Cost of Revenue | $26.8M | -5.1% |
| R&D Expense | $10.5M | -22.6% |
| SG&A Expense | $33.2M | -12.2% |
| Operating Income | $21.2M | +8819.3% |
| Pre-tax Income | $22.3M | +2139.2% |
| Income Tax | $6.7M | +131.9% |
| Net Income | $15.7M | -28.3% |
| EPS (Basic) | $0.79 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.0M | -10.5% |
| Accounts Receivable | $23.3M | -13.2% |
| Current Assets | $63.9M | -8.8% |
| Total Assets | $227.7M | -6.9% |
| Current Liabilities | $48.0M | -10.2% |
| Total Liabilities | $63.9M | -11.7% |
| Stockholders' Equity | $163.8M | -4.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.2M | +305.6% |
| Capital Expenditures | $3.4M | -9.5% |
| Investing Cash Flow | -$3.4M | -130.4% |
| Financing Cash Flow | -$26.7M | -1.7% |
| Free Cash Flow | $22.8M | +749.5% |
| -28.8% |
| EPS (Diluted) | $0.77 | -29.4% |